sorafenib has been researched along with sch 527123 in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (sch 527123) | Trials (sch 527123) | Recent Studies (post-2010) (sch 527123) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 18 | 0 | 12 |
| Protein | Taxonomy | sorafenib (IC50) | sch 527123 (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| C-X-C chemokine receptor type 1 | Homo sapiens (human) | 0.1021 | |
| C-X-C chemokine receptor type 2 | Homo sapiens (human) | 0.1183 | |
| C-X-C chemokine receptor type 2 | Mus musculus (house mouse) | 0.0081 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chu, B; Jiang, Y; Li, Q; Liu, Z; Luo, J; Shi, Z; Xin, Q; Ye, L; Zhan, F; Zhang, X; Zhu, Q | 1 |
2 other study(ies) available for sorafenib and sch 527123
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Design, synthesis and anti-tumor evaluation of 1,2,4-triazol-3-one derivatives and pyridazinone derivatives as novel CXCR2 antagonists.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyridazines; Receptors, Interleukin-8B; Structure-Activity Relationship; Triazoles | 2021 |